US Patent Issued to VitalTE LifeSciences on Aug. 25 for "Dual chamber syringe for administering a hormone encapsulated by a hydrogel" (Nevada, Kansas Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,677, issued on Aug. 25, was assigned to VitalTE LifeSciences Inc. (Reno, Nev.).

"Dual chamber syringe for administering a hormone encapsulated by a hydrogel" was invented by Charles P. Virden (Reno, Nev.), Stephen Harrington (Overland Park, Kan.) and Stella Vnook (Reno, Nev.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A dual chamber syringes for administration of a hormone encapsulated by a hydrogel polymer is described. The dual chamber syringe includes a first chamber, a second chamber, a separator, and a plunger. The first chamber includes a crosslinked methacrylate hyaluronic acid (MHA) polymer that encapsulates the hormone. The crosslinked M...